glp 1 louisiana allows telehealth obesity care amid GLP-1 boom Louisiana Patients Are Losing Coverage

Description

Second, for individuals with class I obesity or those preferring less invasive care, ESG emerges as a compelling alternative

Drugs for the treatment of nausea and vomiting in adults in the emergency department setting

Is the Pill Better Than Shots if Youve Never Taken a GLP-1 Drug Before

Every patient responds to treatment a little differently

Recent Trends in GLP-1 Use and Spending in Medicare Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, new data from the Centers for Medicare & Medicaid Services (CMS) shows that use and spending for these drugs under Medicare has grown substantially in recent years, reflecting their demonstrated effectiveness at treating type 2 diabetes and other conditions